Beltrão
Repurposing drugs for a pan-coronavirus treatment
Scientists from the Beltrao Group at EMBL-EBI and collaborators identified drug targets common to SARS-CoV-2, SARS-CoV-1, and MERS-CoV, three…
Existing drugs can prevent SARS-CoV-2 from hijacking cells
Researchers evaluate how the new coronavirus rewires human proteins for its own replication, and identify several antiviral drugs ready for clinical…
Identifying how potential COVID-19 drugs work
EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living…
Drivers of evolution hidden in plain sight
A rapid, versatile mechanism that modifies proteins is revealed to be crucial for the evolutionary…
EMBL-EBI hosts the Cambridge New Therapeutics Forum
CamNTF hosts meetings around Cambridge, open to all scientists interested in new…
See data in a new light
3D printing, gaming, virtual reality and lenticular posters bring new perspectives to…
Last 6 months:
- January 2021 (7)
- December 2020 (18)
- November 2020 (12)
- October 2020 (21)
- September 2020 (21)
- August 2020 (18)
By year:
By topics:
- Alumni (98)
- Events (161)
- Lab Matters (373)
- Picture of the week (91)
- Science (687)
EMBLetc.
Read the latest Issues of our magazine - EMBLetc.
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive